Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

被引：401

作者：

Mavaddat, Nasim

Pharoah, Paul D. P. ^{[1
,2
]}

Michailidou, Kyriaki ^{[1
]}

Tyrer, Jonathan ^{[2
]}

Brook, Mark N. ^{[3
]}

Bolla, Manjeet K. ^{[1
]}

Wang, Qin ^{[1
]}

Dennis, Joe ^{[1
]}

Dunning, Alison M. ^{[2
]}

Shah, Mitul

Luben, Robert ^{[1
]}

Brown, Judith ^{[1
]}

Bojesen, Stig E. ^{[4
,5
,6
]}

Nordestgaard, Borge G. ^{[4
,5
,6
]}

Nielsen, Sune F. ^{[4
,5
]}

Flyger, Henrik ^{[7
]}

Czene, Kamila ^{[8
]}

Darabi, Hatef ^{[8
]}

Eriksson, Mikael ^{[8
]}

Peto, Julian ^{[9
]}

dos-Santos-Silva, Isabel ^{[9
]}

Dudbridge, Frank ^{[9
]}

Johnson, Nichola ^{[10
]}

Schmidt, Marjanka K. ^{[11
]}

Broeks, Annegien ^{[11
]}

Verhoef, Senno ^{[11
]}

Rutgers, Emiel J. ^{[11
]}

Swerdlow, Anthony ^{[3
,12
]}

Ashworth, Alan ^{[10
]}

Orr, Nick ^{[10
]}

Schoemaker, Minouk J. ^{[3
]}

Figueroa, Jonine ^{[13
]}

Chanock, Stephen J. ^{[13
]}

Brinton, Louise

Lissowska, Jolanta ^{[14
,15
]}

Couch, Fergus J. ^{[16
]}

Olson, Janet E. ^{[17
]}

Vachon, Celine ^{[17
]}

Pankratz, Vernon S. ^{[17
]}

Lambrechts, Diether ^{[18
,19
]}

Wildiers, Hans ^{[20
,21
]}

Van Ongeval, Chantal ^{[23
]}

Van Limbergen, Erik ^{[22
]}

Kristensen, Vessela

Alnaes, Grethe Grenaker ^{[24
]}

Nord, Silje ^{[24
]}

Borresen-Dale, Anne-Lise ^{[24
,25
]}

Nevanlinna, Heli ^{[27
,28
]}

Muranen, Taru A. ^{[27
,28
]}

Aittomaeki, Kristiina ^{[29
]}

机构：

[1] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England

[2] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England

[3] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England

[4] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark

[5] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark

[6] Copenhagen Univ Hosp, Fac Hlth & Med Sci, Herlev, Denmark

[7] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark

[8] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[9] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England

[10] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England

[11] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands

[12] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England

[13] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA

[14] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland

[15] Inst Oncol, Warsaw, Poland

[16] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

[17] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA

[18] VIB, Vesalius Res Ctr, Leuven, Belgium

[19] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium

[20] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium

[21] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium

[22] Univ Hosp Gasthuisberg, Dept Radiat Oncol, Leuven, Belgium

[23] Univ Hosp Gasthuisberg, Dept Radiol, Leuven, Belgium

[24] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway

[25] Univ Oslo, Inst Clin Med, Oslo, Norway

[26] Univ Oslo, Dept Clin Mol Biol, Oslo, Norway

[27] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Hus, Finland

[28] Univ Helsinki, Cent Hosp, Helsinki, Hus, Finland

[29] Univ Helsinki, Dept Clin Genet, Helsinki, Hus, Finland

[30] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[31] Univ Clin Hamburg Eppendorf, Clin Canc Registry, Dept Canc Epidemiol, Hamburg, Germany

[32] Univ Erlangen Nurnberg, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen,Comprehens Canc Ctr Erlangen E, D-91054 Erlangen, Germany

[33] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

[34] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Erlangen, Germany

[35] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany

[36] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany

[37] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany

[38] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[39] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA

[40] Geisel Sch Med Dartmouth, Hanover, NH USA

[41] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Tampa, FL 33612 USA

[42] Harvard Univ, TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA

[43] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[44] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA

[45] Harvard Univ, Sch Med, Boston, MA USA

[46] Inst Canc Res, Sect Canc Genet, London SW3 6JB, England

[47] Genome Inst Singapore, Div Human Genet, Singapore, Singapore

[48] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Human Genotyping CEGEN Unit, Madrid, Spain

[49] Ctr Invest Red Enfermedades Raras, Valencia, Spain

[50] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2015年 / 107卷 / 05期

基金：

芬兰科学院; 英国医学研究理事会; 美国国家卫生研究院; 加拿大健康研究院; 俄罗斯基础研究基金会; 瑞典研究理事会;

关键词：

GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; FAMILY-HISTORY; PREVENTION; PROSTATE; SUBTYPES;

D O I：

10.1093/jnci/djv036

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast cancer risk. Such stratification could guide preventive and screening strategies. However, empirical evidence for genetic risk stratification is lacking. Methods: We investigated the value of using 77 breast cancer-associated single nucleotide polymorphisms (SNPs) for risk stratification, in a study of 33 673 breast cancer cases and 33 381 control women of European origin. We tested all possible pair-wise multiplicative interactions and constructed a 77-SNP polygenic risk score (PRS) for breast cancer overall and by estrogen receptor (ER) status. Absolute risks of breast cancer by PRS were derived from relative risk estimates and UK incidence and mortality rates. Results: There was no strong evidence for departure from a multiplicative model for any SNP pair. Women in the highest 1% of the PRS had a three-fold increased risk of developing breast cancer compared with women in the middle quintile (odds ratio [OR] = 3.36, 95% confidence interval [CI] = 2.95 to 3.83). The ORs for ER-positive and ER-negative disease were 3.73 (95% CI = 3.24 to 4.30) and 2.80 (95% CI = 2.26 to 3.46), respectively. Lifetime risk of breast cancer for women in the lowest and highest quintiles of the PRS were 5.2% and 16.6% for a woman without family history, and 8.6% and 24.4% for a woman with a first-degree family history of breast cancer. Conclusions: The PRS stratifies breast cancer risk in women both with and without a family history of breast cancer. The observed level of risk discrimination could inform targeted screening and prevention strategies. Further discrimination may be achievable through combining the PRS with lifestyle/environmental factors, although these were not considered in this report.

引用

页数：15

共 31 条

[1] Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease
Beral, V
Bull, D
Doll, R
Peto, R
Reeves, G
[J]. LANCET, 2001, 358 (9291) : 1389 - 1399
[2] Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, Archie
Welch, H. Gilbert
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21) : 1998 - 2005
[3] Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Bojesen, Stig E.
Pooley, Karen A.
Johnatty, Sharon E.
Beesley, Jonathan
Michailidou, Kyriaki
Tyrer, Jonathan P.
Edwards, Stacey L.
Pickett, Hilda A.
Shen, Howard C.
Smart, Chanel E.
Hillman, Kristine M.
Mai, Phuong L.
Lawrenson, Kate
Stutz, Michael D.
Lu, Yi
Karevan, Rod
Woods, Nicholas
Johnston, Rebecca L.
French, Juliet D.
Chen, Xiaoqing
Weischer, Maren
Nielsen, Sune F.
Maranian, Melanie J.
Ghoussaini, Maya
Ahmed, Shahana
Baynes, Caroline
Bolla, Manjeet K.
Wang, Qin
Dennis, Joe
McGuffog, Lesley
Barrowdale, Daniel
Lee, Andrew
Healey, Sue
Lush, Michael
Tessier, Daniel C.
Vincent, Daniel
Bacot, Francis
Vergote, Ignace
Lambrechts, Sandrina
Despierre, Evelyn
Risch, Harvey A.
Gonzalez-Neira, Anna
Rossing, Mary Anne
Pita, Guillermo
Doherty, Jennifer A.
Alvarez, Nuria
Larson, Melissa C.
Fridley, Brooke L.
Schoof, Nils
Chang-Claude, Jenny
[J]. NATURE GENETICS, 2013, 45 (04) : 371 - 384
[4] Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Broeks, Annegien
Schmidt, Marjanka K.
Sherman, Mark E.
Couch, Fergus J.
Hopper, John L.
Dite, Gillian S.
Apicella, Carmel
Smith, Letitia D.
Hammet, Fleur
Southey, Melissa C.
Van 't Veer, Laura J.
de Groot, Renate
Smit, Vincent T. H. B. M.
Fasching, Peter A.
Beckmann, Matthias W.
Jud, Sebastian
Ekici, Arif B.
Hartmann, Arndt
Hein, Alexander
Schulz-Wendtland, Ruediger
Burwinkel, Barbara
Marme, Frederik
Schneeweiss, Andreas
Sinn, Hans-Peter
Sohn, Christof
Tchatchou, Sandrine
Bojesen, Stig E.
Nordestgaard, Borge G.
Flyger, Henrik
Orsted, David D.
Kaur-Knudsen, Diljit
Milne, Roger L.
Perez, Jose I. Arias
Zamora, Pilar
Menendez Rodriguez, Primitiva
Benitez, Javier
Brauch, Hiltrud
Justenhoven, Christina
Ko, Yon-Dschun
Hamann, Ute
Fischer, Hans-Peter
Bruening, Thomas
Pesch, Beate
Chang-Claude, Jenny
Wang-Gohrke, Shan
Bremer, Michael
Karstens, Johann H.
Hillemanns, Peter
Doerk, Thilo
Nevanlinna, Heli A.
[J]. HUMAN MOLECULAR GENETICS, 2011, 20 (16) : 3289 - 3303
[5] Public health implications from COGS and potential for risk stratification and screening
Burton, Hilary
Chowdhury, Susmita
Dent, Tom
Hall, Alison
Pashayan, Nora
Pharoah, Paul
[J]. NATURE GENETICS, 2013, 45 (04) : 349 - 351
[6] Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Cuzick, Jack
Sestak, Ivana
Bonanni, Bernardo
Costantino, Joseph P.
Cummings, Steve
DeCensi, Andrea
Dowsett, Mitch
Forbes, John F.
Ford, Leslie
LaCroix, Andrea Z.
Mershon, John
Mitlak, Bruce H.
Powles, Trevor
Veronesi, Umberto
Vogel, Victor
Wickerham, D. Lawrence
[J]. LANCET, 2013, 381 (9880) : 1827 - 1834
[7] Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
Darabi, Hatef
Czene, Kamila
Zhao, Wanting
Liu, Jianjun
Hall, Per
Humphreys, Keith
[J]. BREAST CANCER RESEARCH, 2012, 14 (01):
[8] Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, Douglas F.
Pooley, Karen A.
Dunning, Alison M.
Pharoah, Paul D. P.
Thompson, Deborah
Ballinger, Dennis G.
Struewing, Jeffery P.
Morrison, Jonathan
Field, Helen
Luben, Robert
Wareham, Nicholas
Ahmed, Shahana
Healey, Catherine S.
Bowman, Richard
Meyer, Kerstin B.
Haiman, Christopher A.
Kolonel, Laurence K.
Henderson, Brian E.
Le Marchand, Loic
Brennan, Paul
Sangrajrang, Suleeporn
Gaborieau, Valerie
Odefrey, Fabrice
Shen, Chen-Yang
Wu, Pei-Ei
Wang, Hui-Chun
Eccles, Diana
Evans, D. Gareth
Peto, Julian
Fletcher, Olivia
Johnson, Nichola
Seal, Sheila
Stratton, Michael R.
Rahman, Nazneen
Chenevix-Trench, Georgia
Bojesen, Stig E.
Nordestgaard, Borge G.
Axelsson, Christen K.
Garcia-Closas, Montserrat
Brinton, Louise
Chanock, Stephen
Lissowska, Jolanta
Peplonska, Beata
Nevanlinna, Heli
Fagerholm, Rainer
Eerola, Hannaleena
Kang, Daehee
Yoo, Keun-Young
Noh, Dong-Young
Ahn, Sei-Hyun
[J]. NATURE, 2007, 447 (7148) : 1087 - U7
[9] Ferlay J, IARC CANCERBASE, V11
[10] Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
French, Juliet D.
Ghoussaini, Maya
Edwards, Stacey L.
Meyer, Kerstin B.
Michailidou, Kyriaki
Ahmed, Shahana
Khan, Sofia
Maranian, Mel J.
O'Reilly, Martin
Hillman, Kristine M.
Betts, Joshua A.
Carro, Thomas
Bailey, Peter J.
Dicks, Ed
Beesley, Jonathan
Tyrer, Jonathan
Maia, Ana-Teresa
Beck, Andrew
Knoblauch, Nicholas W.
Chen, Constance
Kraft, Peter
Barnes, Daniel
Gonzalez-Neira, Anna
Rosario Alonso, M.
Herrero, Daniel
Tessier, Daniel C.
Vincent, Daniel
Bacot, Francois
Luccarini, Craig
Baynes, Caroline
Conroy, Don
Dennis, Joe
Bolla, Manjeet K.
Wang, Qin
Hopper, John L.
Southey, Melissa C.
Schmidt, Marjanka K.
Broeks, Annegien
Verhoef, Senno
Cornelissen, Sten
Muir, Kenneth
Lophatananon, Artitaya
Stewart-Brown, Sarah
Siriwanarangsan, Pomthep
Fasching, Peter A.
Loehberg, Christian R.
Ekici, Arif B.
Beckmann, Matthias W.
Peto, Julian
Silva, Isabel dos Santos
[J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 92 (04) : 489 - 503

← 1 2 3 4 →